Browsing by Author Drury, P

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2007Abstract 3691: Features Of Metabolic Syndrome Identify Individuals With Type 2 Diabetes Mellitus At High Risk For Cardiovascular Events And Greater Absolute Benefits Of FenofibrateBarter, Philip; Copt, Samuel; Keech, Anthony (Tony); Pardy, Christopher; Best, James; D'Emden, Michael C.; Drury, P; Ehnholm, Christian; FIELD study investigators, Fenofibrate Intervention and Event Lowering in Diabetes; Kesaniemi, Y. Antero; Scott, Russell; Taskinen, M.; Tse, Dana; Central Clinical School: Heart Research Institute; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreAbstract 3691: Features Of Metabolic Syndrome Identify Individuals With Type 2 Diabetes Mellitus At High Risk For Cardiovascular Events And Greater Absolute Benefits Of Fenofibrate, Circulation (Baltimore), vol.116, N/A,pp II_838-N/A
2008Can self-rated health scores be used for risk prediction in patients with type 2 diabetes?Clarke, Philip; Hayes, Alison; Keech, Anthony (Tony); Simes, Robert John; Drury, P; Glasziou, Paul; School of Public Health: Public Health; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreCan self-rated health scores be used for risk prediction in patients with type 2 diabetes?, Diabetes Care, vol.31, 4, 2008,pp 795-797
2005Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.Barter, Philip; Best, James; Davis, Tracey; Forder, Peta; Glasziou, Paul; Keech, Anthony (Tony); Pillai, Avineshwaran; Scott, R; Simes, Robert John; Sullivan, David; Taskinen, M; Drury, P; et, al; Kesaniemi, Y. Antero; Central Clinical School: Medicine; Medicine Faculty Office; Western Clinical School: Medicine (Westmead); School of Public Health: NH&MRC Clinical Trials Centre; Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Molecular Bioscience; Central Clinical School: MedicineEffects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial., The Lancet, vol.366,(9500),2005,pp 1849-1861